Lung Foundation Australia’s Board of Directors is delighted to announce the appointment of Associate Professor Lucy Morgan as the organisation’s new Chair.
Leading Respiratory Physician, A/Prof Morgan, has dedicated her career to improving the lives of Australians impacted by lung disease. She is a passionate advocate for equitable access to best-practice clinical care and for gender equity in research and clinical leadership.
A/Prof Morgan has a long-standing history with Lung Foundation Australia, having chaired and contributed to numerous committees. Since receiving the prestigious Boehringer Ingelheim Lung Foundation Australia COPD Fellowship in 1999, she has been working from lab to bedside, giving hope to those who need it most.
“I am deeply honoured to become Chair of an organisation that is so close to my heart, and to work with the Board, CEO and the Lung Foundation Australia team to continue to build on the incredible success achieved to-date under Professor Christine Jenkins’ leadership,” A/Prof Morgan said.
“Joining the Lung Foundation Australia Board in 2019 has offered me the chance to make a difference to the lives of many more Australians by not only advocating for increased funding for research, but by changing the attitudes of voters and policy makers toward issues of lung health.”
After seven years of outstanding leadership, Lung Foundation Australia’s succeeding Chair, Professor Christine Jenkins AM, made the decision to hand over the reins but will remain a Member of the Board where she will continue to play an integral role in the organisation’s success.
“It has been truly rewarding to serve as Chair of Lung Foundation Australia through its evolution over the last seven years. I am incredibly proud of our accomplishments over this time. The organisation has expanded its services to better address the gaps in care for Australians diagnosed with lung disease or lung cancer, and has continued to support best-practice diagnosis and clinical care through health professional education and training,” Prof Jenkins said.
“In recent times, in addition to delivering our ongoing services and programs, our small but mighty team of staff delivered real-time support and information during the pandemic. This internationally recognised and trusted information provided the community with an extensive range of practical tools and resources to help protect themselves against the virus and navigate the unique challenges of isolation.
“As we look ahead to what life with COVID-19 may be like, the team remain focused on how we can continue to support not only our community, but also those who are personally impacted by COVID-19 – all while continuing to ensure every Australians touched by lung disease or lung cancer has access to the diagnosis, treatment, support and care they deserve. I have every confidence in A/Prof Morgan’s leadership and look forward to continuing to work with Lucy, the Board, CEO and Lung Foundation Australia team.”
Lung Foundation Australia CEO, Mr Mark Brooke, expressed his gratitude for Professor Jenkins’ leadership. “I am deeply grateful to Professor Jenkins for her vision, dedication and passion which has led to significant acceleration and growth of the organisation’s programs and services. Equally I am excited for what the future holds under Lucy’s leadership. Lucy brings a wealth of expertise and passion, which will be critical to our ability to continually grow and improve the outcomes for people living with lung disease and lung cancer.”
A/Prof Lucy Morgan
Associate Professor Lucy Morgan
A/Prof Morgan is a Respiratory Physician and a passionate advocate for equity of access to benchmark clinical care for all Australians with lung disease. She advocates for gender equity in research and clinical leadership, with clinical roles at Sydney’s Concord Hospital, Nepean Hospital and Macquarie University Private Hospital.
A/Prof Morgan has had a long history with Lung Foundation Australia.
Since being awarded the Lung Foundation Australia Boehringer Ingelheim COPD Fellowship in 1999, she has gone on to chair the Lung Foundation Australia Palliative and Supportive Care Committee, and the Respiratory Infectious Diseases Committee.
She has also been a member of the Australasian Lung Cancer Trials Group, COPD-X Committee, Lung Foundation Australia Clinical Council, and more recently, the Lead Clinician of Lung Foundation Australia’s Australian Bronchiectasis Registry.
Prof Christine Jenkins AM
Prof Jenkins AM has a strong commitment to respiratory practice and research, particularly in the management of asthma and Chronic Obstructive Pulmonary Disease (COPD). She is the Professor of Respiratory Medicine at the University of New South Wales Sydney, Clinical Professor at the University of Sydney, and heads the Respiratory Group at The George Institute for Global Health.
Prof Jenkins has played a major role in advocacy and leadership for lung health in Australia.
She’s made a significant impact in community sector with over 200 publications, three books, contributions to respiratory guidelines in Australia and internationally, and senior leadership positions for government, health professional, and not-for-profit organisations. She was awarded Member, Order of Australia in 2002 for Services to Respiratory Medicine, was President of the Thoracic Society of Australia and New Zealand from 2007-2009, and made a Fellow of the Australian Academy of Health and Medical Sciences in 2021.